The effects of changes in ionic environment and modification of adrenergic function on the vascular responses to sympathomimetic amines.
D000818:Animals; D002118:Calcium / Q000494:pharmacology*; D003042:Cocaine / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D004357:Drug Synergism; D008274:Magnesium / Q000494:pharmacology*; D008297:Male; D008638:Mesenteric Arteries / Q000187:drug effects*; D008680:Metaraminol / Q000037:antagonists & inhibitors / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects*; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D009655:Octopamine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology*; D014439:Tyramine / Q000037:antagonists & inhibitors / Q000494:pharmacology
D013566:Sympathomimetics; D009655:Octopamine; D010042:Ouabain; D008680:Metaraminol; D012110:Reserpine; D008274:Magnesium; D003042:Cocaine; D002118:Calcium; D009526:Nialamide; D003891:Desipramine; D009638:Norepinephrine; D014439:Tyramine